Relief Cardiovascular announces first human use of smart heart implant
September 30, 2025
Relief Cardiovascular today announced the successful first-in-human use of its transcatheter smart heart implant.
Relief Cardiovascular today announced the successful first-in-human use of its transcatheter smart heart implant.
Abbott (NYSE: ABT)+
said Health Canada authorized its Esprit BTK Everolimus Eluting Resorbable Scaffold System, a dissolving stent for patients with chronic limb-threatening ischemia (CLTI) below the knee.